Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


GREY:FRTX - Post by User

Comment by pierrelebelon Aug 05, 2023 11:35am
134 Views
Post# 35574803

RE:RE:just my considerations

RE:RE:just my considerations
tylerreddick wrote "... They overvalued Strath and undervalued PIPE. We got screwed, pure and simple...."

No poster on this board has the information leading to that conclusion.

The folks at Riverstone have over $260,000,000 invested in Pipestone and they agreed that getting 9% of Strathcona was fair.  They have a lot more money invested in that transaction than all posters on this board combined. Prior to accepting the offer they obviously had access to information (Strathcona's financials) that posters here know nothing about. 

It is time to trust that the controlling shareholders (Riverstone) are smart and make decisions that benefit them financially, and us by extention.  Check their background and you will agree with me.

Patience will be rewarded.

<< Previous
Bullboard Posts
Next >>